Latest News

CommSec Executive Series Interview

24 April 2018

Andrew McLellan, Bluechiip Limited Managing Director, was recently interviewed as part of the CommSec Executive Series. In the interview, Andrew McLellan explains the Company’s technology, progress with Original Equipment Manufacturers (OEMs) and other recent activities. A video recording of the interview can be found here: https://www.bluechiip.com/investor/company-overview/ The original ASX announcement can be found here: https://www.asx.com.au/asxpdf/20180424/pdf/43tg365ccmlj2h.pdf

Discover More >

Bluechiip Corporate Overview and March 2018 Update

14 March 2018

Please find in the link below Bluechiip corporate overview and March 2018 corporate update https://www.asx.com.au/asxpdf/20180314/pdf/43sdwbsfnwfkgv.pdf Highlights: • Dramatically increasing partner pipeline, 21 developer kits sold up from 16 last quarter • Highly differentiated, expanding, protected IP portfolio • Large growing target market with very large adjacent markets • Well advanced product development entering manufacture •…

Discover More >

Managing Director, Andrew McLellan on 1H FY18 results and outlook

26 February 2018

In this Open Briefing®, Andrew discusses: Bluechiip progression from being in development into a manufacturing company Accelerating production volumes and revenue generation Receipt of a $776k R & D tax refund in January, with more to come and current $2m cash balance Labcon $1m order status and marketing a range of vials incorporating Bluechiip technology…

Discover More >

Labcon Begins Production of Bluechiip-Enabled Consumables

19 February 2018

Highlights: Labcon North America has commenced manufacturing Bluechiip-enabled consumables Labcon’s ColdPoint® Bluechiip-enabled vials were displayed at a major trade show in California Bluechiip has scaled up production to meet Labcon’s demand. Three shipments completed Orders in hand for a dramatic increase in Bluechiip tag volumes each month over the coming year The consumables range addresses…

Discover More >

Bluechiip featured in a case study for the Australian R&D tax incentive programme

18 January 2018

Smart chips, readers and software for low‑temperature environments prove a winning formula for Melbourne‑based manufacturing company Bluechiip has been featured in a case study for the Australian R&D tax incentive programme. Read the full article below: A 13 year‑long R&D journey has resulted in an innovative technology ripe to disrupt an “exploding market”. Company Profile…

Discover More >

Bluechiip Receives AU$1 Million Initial Order From US Partner

05 December 2017

Bluechiip Limited [ASX:BCT], a leader in the development of sample tracking technology for harsh environments, today announced that a licensed Original Equipment Manufacturer (OEM) partner in the United States has placed orders for Bluechiip chips, readers, software and services valued at over A$1 million. This licensed OEM partner will use Bluechiipenabled consumables to address a…

Discover More >

Corporate Video – Preparing For Growth

23 October 2017

Bluechiip Limited, a leader in the development of sample tracking technology for harsh environments, has produced a short fiveminute video in which Managing Director/CEO Andrew McLellan explains the company’s partnerships with Original Equipment Manufacturers (OEMs), and its plans for growth across several key sectors. Read the full ASX announcement > Contact Bluechiip for more information…

Discover More >

Annual General Meeting – Monday 13 November 2017 10.00am aedt

22 October 2017

Notice is given that the Annual General Meeting (AGM) of the members of Bluechiip Limited will be held at the time and location, and to conduct the business, specified below: Date: Monday 13 of November 2017 Time: 10:00am (Melbourne time) Location: The offices of Phillips Ormonde Fitzpatrick, Level 16, 333 Collins St, Melbourne, Vic 300…

Discover More >

Company Update – Scaling Production

19 October 2017

Highlights: Strong revenue growth in September quarter forecast to accelerate through FY18 Scaling up production of readers and chips for customers Key customers currently tooling for production Labcon North America progressing to tooling trials Genea Biomedx licence income received Patent granted for ‘Temperature Sensing and Heating Device’ $2.96m cash in bank provides clear runway to…

Discover More >